Evidence map›Paper›PMID 41075075›Full record

ArticleMolecular biology reports2025

Validation of a dual-purpose conventional PCR strategy for SARS-CoV-2 detection and lineage screening in resource-limited laboratories.

Liliana Iñiguez-Gutiérrez, María Teresa Magaña-Torres, José Daniel Ruiz-Carrillo, Luz Alicia González-Hernández, Jaime Federico Andrade-Villanueva, Brenda Marely Ruelas-Abarca, Ivonne Montserrat Lara-López, Teresita de Jesús Hernández-Flores

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liliana Iñiguez-GutiérrezDepartamento Disciplinas Especializantes I, Decanato de Ciencias de la Salud, Universidad Autónoma de Guadalajara, Jalisco, 45110, Zapopan, Mexico.ORCID http://orcid.org/0000-0001-9178-7686
María Teresa Magaña-TorresDivisión de Genética, Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Jalisco, 44340, Guadalajara, Mexico.
José Daniel Ruiz-CarrilloCoordinación de Medicina Preventiva, Hospital Regional de Alta Especialidad de Tlajomulco de Zúñiga, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Jalisco, 45640, Tlajomulco de Zúñiga, Mexico.ORCID http://orcid.org/0000-0001-5929-3707
Luz Alicia González-HernándezUnidad de VIH, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Jalisco, 44350, Guadalajara, Mexico.ORCID http://orcid.org/0000-0002-7163-0566
Jaime Federico Andrade-VillanuevaUnidad de VIH, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Jalisco, 44350, Guadalajara, Mexico.ORCID http://orcid.org/0000-0003-1948-655X
Brenda Marely Ruelas-AbarcaLicenciatura Químico Farmacéutico Biólogo, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara, 44430, Jalisco, Mexico.
Ivonne Montserrat Lara-LópezIngeniería en Alimentos y Biotecnología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara, 44430, Jalisco, Mexico.
Teresita de Jesús Hernández-FloresInstituto de Investigación en Recursos Humanos, Departamento de Disciplinas Filosófico, Metodológicas e Instrumentales, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, 44340, Guadalajara, Mexico. teresita.hflores@academicos.udg.mx.ORCID http://orcid.org/0000-0002-2849-8635

Funding

Consejo Estatal de Ciencia y Tecnología de Jalisco Project FODECIJAL 2021-9761Universidad de Guadalajara 9761
6 · The paper itself

Abstract

purposeAffordable molecular tools for SARS-CoV-2 surveillance are crucial, particularly in settings where access to advanced technologies is limited. This study aimed to validate a dual-purpose strategy based on conventional PCR and polyacrylamide gel electrophoresis for both diagnosis and lineage screening.

methodsFifty-five nasopharyngeal swab samples were analyzed through RNA extraction, reverse transcription, and conventional PCR targeting the SARS-CoV-2 spike (S) gene. Amplicons were visualized on 6% polyacrylamide gels, and the diagnostic results were compared with those of RT‒qPCR. Fragment size shifts via electrophoresis were used for lineage inference and confirmed via Sanger sequencing.

resultsThe method demonstrated 100% concordance with RT‒qPCR for both diagnostic detection and accurate lineage classification in all analyzed samples. Characteristic gel migration patterns allowed identification of Omicron sublineages, and two samples presented unique mutational profiles not previously recorded in databases at the time of sampling. One of them matched the BA.2.86 lineage later reported in July 2024, indicating the method's potential for early variant detection. The approach also enabled multiplex PCR and internal control verification using a human LDLR gene fragment.

conclusionThis dual-purpose PCR strategy offers a cost-effective, scalable, and technically accessible alternative for SARS-CoV-2 surveillance in low-resource settings. Its high diagnostic reliability and ability to detect emerging variants through amplicon profiling support its implementation as a screening tool, pending broader validation across diverse populations.

Indexed as

COVID-19COVID-19 Nucleic Acid TestingPolymerase Chain ReactionSARS-CoV-2HumansMultiplex Polymerase Chain ReactionNasopharynxReal-Time Polymerase Chain ReactionRNA, ViralSpike Glycoprotein, CoronavirusRNA, ViralSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Conventional PCRGenomic surveillanceLineage screeningLow-resource settingsPolyacrylamide gel electrophoresisSanger sequencingSARS-CoV-2

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.